Sherry Cai Liu, CFA

Sherry Cai Liu, CFA has a diverse and extensive work experience spanning across various industries. Sherry is currently serving as the Director of FP&A / Head of FP&A System and Reporting at SK Life Science, Inc. Since joining in 2019. Prior to this, they held key positions at Roivant Sciences from 2017 to 2018, including Finance Director and Head of FP&A for the Axovant Subsidiary, as well as Associate Director of Clinical Finance / R&D FP&A. Before that, they worked at Regeneron Pharmaceuticals, Inc. from 2013 to 2017, serving as a Senior Manager in Commercial Alliance Finance and as a Project Lead in Clinical Finance Clinical Trial Payment Solutions Implementation. Sherry also gained valuable experience as a Senior Finance Manager at Warner Chilcott in 2013 and as a Finance Manager at Johnson & Johnson from 2006 to 2013. Sherry began their career in the finance industry as a Fixed Income Credit Analyst at Standard & Poor's from 2003 to 2006 and as a Research Associate in Equity Research at Morgan Stanley Smith Barney from 1998 to 2001. Overall, Sherry Cai Liu, CFA brings a wealth of knowledge and expertise in financial planning, analysis, and strategic decision-making to their role.

Sherry Cai Liu, CFA has a strong educational background in accounting, finance, economics, and mathematics. Sherry obtained their Master of Business Administration (M.B.A.) with a focus on Accounting & Finance from NYU Stern School of Business between 2001 and 2003. Prior to their MBA, they completed their Bachelor's of Science degree in Economics & Mathematics at Dartmouth College from 1995 to 1998.

Additionally, Sherry Cai Liu has also obtained the Chartered Financial Analyst (CFA) certification from the Association for Investment Management & Research, although the specific month and year of attainment are not provided.